6550--Molecular Oncology-MSI Testing

Description

{"description":"THIS REQUEST FOR INFORMATION (RFI) IS ISSUED SOLELY FOR INFORMATION AND PLANNING PURPOSES ONLY AND DOES NOT CONSTITUTE A SOLICITATION.\nTHE SUBMISSION OF PRICING, CAPABILITIES FOR PLANNING PURPOSES, AND OTHER MARKET INFORMATION IS HIGHLY ENCOURAGED AND ALLOWED UNDER THIS RFI IN ACCORDANCE WITH (IAW) FAR 15.201(e).\n\nDISCLAIMER\nThis RFI is issued solely for information and planning purposes only and does not constitute a solicitation. All information received in response to this RFI that is marked as proprietary will be handled accordingly. IAW FAR 15.201(e), responses to this notice are not offers and cannot be accepted by the Government to form a binding contract. Responders are solely responsible for all expenses associated with responding to this RFI.\nSOURCES SOUGHT DESCRIPTION\nThis is NOT a solicitation announcement. This is a sources sought/RFI only. The purpose of this sources sought/RFI is to gain knowledge of potential qualified sources and their size classification relative to NAICS 325413 (size standard of 1,250 Employees). Responses to this sources sought will be used by the Government to make appropriate acquisition decisions. After review of the responses to this sources sought, a solicitation announcement may be published. Responses to this sources sought synopsis are not considered adequate responses for a solicitation announcement. \n\nThe Department of Veterans Affairs (VA), VISN 22 Network Contracting Office, is seeking sources that can provide a MSI Testing Reagent Cartridges as Reagent Rental needed to perform inhouse single gene molecular testing that at a minimum meets the following salient characteristics with a brand name or equal product for the VA Greater Los Angeles Healthcare System:\n\nSALIENT CHARACTERISTICS\nThe assay shall be fully automated, ready to made reagent with no reagent preparation required\nThe assay shall provide the following MSI testing characteristics:\nProvide a result in approximately 150 minutes.\nNo sample extraction required prior to use. \nTesting volume that can be performed on a minimum of 1 slice of FFPE tissue section.\nEliminate use of external quality control.\nQualitative detection of mutations in 7 novel MSI loci (ACVR2A, BTBD7, DIDO1, MRE11, RYR3, SEC31A, and SULF2).\n\nBRAND NAME OR EQUAL INFORMATION\n\nMFG\nProduct Name / Description\nProduct Number\nEst. Annual Quantity\nBiocartis\nIdylla MSI Assay\nA0101/6\n50\nBiocartis\nIdylla Console (ORR)\nP1010\n1\nBiocartis\nIdylla Instrument (ORR)\nP0010\n3\n\nThe information identified above is intended to be descriptive, not restrictive and to indicate the quality of the supplies/services that will be satisfactory. It is the responsibility of the interested source to demonstrate to the government that the interested parties can provide the supplies/services that fulfill the required specifications. \nIf you are interested, and are capable of providing the sought out supplies/services, please provide the requested information as well as the information indicated below. Response to this notice should include company name, address, point of contact, size of business pursuant to the following questions: \n(1) Please indicate the size status and representations of your business, such as but not limited to: Service-Disabled Veteran Owned Small Business (SDVOSB), Veteran Owned Small Business (VOSB), Hubzone, Woman Owned Small Business (WOSB), Large Business, etc.\n(2) Is your company considered small under the NAICS code identified under this RFI?\n(3) Are you the manufacturer or distributor of the items being referenced above (or equivalent product/solution)? What is the manufacturing country of origin of these items?\n(4) If you re a small business and you are an authorized distributor/reseller for the items identified above (or equivalent product/solution), do you alter; assemble; modify; the items requested in any way? If you do, state how and what is altered; assembled; modified?\n(5) Does your company have an FSS contract with GSA or the NAC or are you a contract holder with NASA SEWP or any other federal contract for the requested items? If so, please provide the contract type and number.\n(6) If you are an FSS GSA/NAC or NASA SEWP contract holder or other federal contract holder, are the referenced items/solutions available on your schedule/contract?\n(7) Please provide general pricing for your products/solutions for market research purposes.\n(8) Please submit your capabilities in regard to the salient characteristics/statement of work being provided and any information pertaining to equal to items to establish capabilities for planning purposes.\n(9) Please provide your Unique Entity ID (UEI) number.\n*** Submissions addressing Section (8) should show clear, compelling and convincing*** evidence that all equal to items\" meet all required salient characteristics.\nResponses to this notice shall be submitted via email to Samuel.Han@va.gov. Telephone responses shall not be accepted. Responses must be received no later than Thursday, April 23, 2026 by 1:00 p.m. Pacific Time. If a solicitation is issued it shall be announced at a later date, and all interested parties must respond to that solicitation announcement separately from the responses to this request for information. Responses to this notice are not a request to be added to a prospective bidders list or to receive a copy of the solicitation.\n\n"}